October 27, 2014
In a previous blog I said that I had requested access to documents on the dealings between DG Enterprise and pharmaceutical industry associations while the EMA was developing (and watering down) its transparency policy. I was given a few “mostly harmless” documents but the rest were refused on the grounds that they contained material that was protected by data protection laws. I have just submitted an appeal, or “confirmatory application,” against this refusal.
I was told that it was open to me to argue that the documents (that I had not seen) would not undermine the privacy and integrity of (unnamed) individuals. Well, unless and until I see at least a list or register of such documents I am not going to take that route.
I was not told that they could disclose the documents in part by removing any bit that meets any of the exceptions for disclosure such as the […]